Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Corporate Sponsors – LILA International Logistics Ltd
🏆Thank you so much to LILA International Logistics Ltd, who became one of Neuroendocrine Cancer UK's 'Corporate Champions' and kindly sponsored the production of our newly branded fundraising t-shirts. LILA reached out to us and wanted to show their support, after the...
Neuroendocrine Cancer UK Ambassador, Simon
Please join us in welcoming our newest Ambassador, Simon to the team 🦋 Simon is 38, husband to Amy and father to three girls. Previously a Senior Vice Principal in secondary education. Here's Simon's story: 💬 I was diagnosed in October 2018 (aged 35) with two...
Quality of Life Survey
Public Health England (PHE), NHS England and NHS Improvement (NHSE&I) have launched a nationwide Cancer Quality of Life Survey to find out how quality of life may have changed for people diagnosed with cancer. The information collected from the survey will help us...